| Description: | Phase II Trial to Evaluate Benefit of Early Switch from first-line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the opposite sequence |
|---|
| Link: | http://clinicaltrials.gov/ct2/show/NCT01718353 | ||
|---|---|---|---|
| Site: | Johns Hopkins University | ||
| Principal Investigator: | Contact: For site information, send an email with site number 840002 | to | Contact-Us@sanofi.com |